2018

10 items

May 16, 2018

Castle Creek Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for Diacerein 1% Ointment for Epidermolysis Bullosa
PARSIPPANY, N.J., May 16, 2018 – Castle Creek [...]
January 4, 2018

Castle Creek Pharmaceuticals to Participate in 5th Annual Dermatology Summit
Biopharma company developing therapies for orphan dermatologic conditions [...]